Macular oedema
Intravitreal triamcinolone versus laser photocoagulation as a primary treatment for diabetic macular oedema - a comparative pilot study
... Patients were properly positioned on a stable chair with the chin rested on the slit lamp that was mounted with a laser wavelength, Carl Zeiss Visulas 532S laser system. Patients were given grid or focal laser depending ...
6
Treatments for macular oedema following central retinal vein occlusion : systematic review
... test the safety and effectiveness of minocycline as a treat- ment for CRVO in around 20 patients with macular oedema secondary to CRVO. Both groups received monthly intravitreal bevacizumab injections over ...
13
Intraocular pressure rise is predictive of vision improvement after intravitreal triamcinolone acetonide for diabetic macular oedema: a retrospective analysis of data from a randomised controlled trial
... The ocular safety of IVTA treatment has been thor- oughly explored [6-8,13-16]. The most common adverse events of IVTA treatment are intraocular pressure (IOP) rise and accelerated cataract formation, particularly pos- ...
5
Cost of diabetic retinopathy and macular oedema in a population, an eight year follow up
... diabetic macular oedema, carried out mathematical studies, wrote the Discussion, and made a critical review, contributing to the final approval of the version for ...
7
A MULTIDIMENSIONAL APPROACH TO CLINICALLY SIGNIFICANT MACULAR OEDEMA- AN OBSERVATIONAL SINGLE CASE STUDY .......
... Immediate after this shocking incidence, he consult- ed a OPTHALMOLOGIST as the blurrness of vision worsened within a week and was diagnosed with diabetic macular oedema BE, he was immediately treated with ...
6
Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusion
... macular oedema and fellow eye characteristics, were not reported in all studies. These factors needed to be accounted for in the comparison to prevent biases in the analyses [25,26]. With the Bayesian model ...
13
Assessment of Severity Level for Diabetic Macular Oedema Using Machine Learning Algorithms
... The primary signs of the DME are neo-vascularization and abnormalities in blood vessels which were detected by using Fuzzy K-Means Clustering. This segmentation algorithm detects the presence and location of patholo- ...
8
Efficacy of additional topical betamethasone in persistent cystoid macular oedema after carbonic anhydrase inhibitor treatments in retinitis pigmentosa
... What is already known about this subject? Cystoid macular oedema (CMO), a vision-threatening condition, is one of the most frequent complications in retinitis pigmentosa (RP). Although various treatment ...
6
The Efficacy of Sodium-Glucose Cotransporter 2 (SGLT2) inhibitors for the treatment of chronic diabetic macular oedema in vitrectomised eyes: a retrospective study
... Diabetic macular oedema (DMO) is a well- known and devastating complication of diabetes mellitus (DM) and is characterised by thickening of the macula due to accumu- lation of intraretinal and/or subretinal ...
6
Health state utilities in patients with diabetic retinopathy, diabetic macular oedema and age-related macular degeneration: a systematic review
... Age-related macular degeneration; BGV: Bilateral good vision; BSE: Better-seeing eye; CINAHL: Cumulative Index of Nursing and Allied Health Literature; DMO: Diabetic macular oedema; DR: Diabetic ...
13
Treating Diabetic Macular Oedema (DMO): real world UK clinical outcomes for the 0.19mg Fluocinolone Acetonide intravitreal implant (Iluvien™) at 2 years
... Worldwide 422 million people have diabetes [1]. A third of these people have diabetic retinopathy (DR) and of these a further third have vision threatening DR includ- ing diabetic macular oedema (DMO) [2]. ...
7
Drug treatment of macular oedema secondary to central retinal vein occlusion : a network meta analysis
... Central retinal vein occlusion (CRVO) dra- matically reduces an individual ’ s functioning and quality of life. 1 It is estimated that the 15-year cumulative incidence of CRVO is 0.5%. 2 Visual loss is caused by ...
15
Efficacy and safety of widely used treatments for macular oedema secondary to retinal vein occlusion: a systematic review
... of macular oedema at baseline was shorter in BRAVO than GENEVA ...of macular oedema was calculated at screening, up to 28 days before the base- line visit, which reduces the potential ...
15
<p>Burden Of Treatment Among Patients Undergoing Intravitreal Injections For Diabetic Macular Oedema In Australia</p>
... with macular oedema impacted their ability to work, 48% stated it affected the kind of work they can do and less freedom to decide their employment situation and 36% stated it affected the amount of time ...
9
Clinically meaningful visual improvements and predictors of early vision gains with ranibizumab for diabetic macular oedema
... and macular oedema identified by time-domain optical coherence tomog- ...receive macular laser therapy according to protocol-specified criteria; panretinal laser was available as clinically ...
8
Evaluation of effect of bevacizumab on central subfield macular thickness in the injected and contralateral (untreated) eye of patients with bilateral diabetic macular oedema
... We recommend treating cases of bilateral DME only after evaluation of the fellow eye. Some of the benefits in treating one eye instead of both initially are reduced pain/discomfort, risk for ocular complication and in ...
5
The relative clinical effectiveness of ranibizumab and bevacizumab in diabetic macular oedema : an indirect comparison in a systematic review
... abstracts—including those of the Association for Research in Vision and Ophthalmology, American Diabetes Association, and European Association for the Study of Diabetes—from 2002 to November 2011. No new studies were ...
17
The effectiveness of pharmacological agents for the treatment of uveitic macular oedema (UMO): a systematic review protocol
... Macular oedema accounts for 41 % of visual impair- ment and 29 % of blindness in uveitis [6, ...cystoid macular oedema being present in 38 % of eyes with similar distribution across ...
7
<p>Real Life Experience of Dexamethasone Implant in Refractory Diabetic Macular Oedema</p>
... Diabetic macular oedema (DMO), one of the most severe complications of diabetes in the eye, is the leading cause of visual impairment in working-age population in developed ...cant macular ...
8
Macular thickness amplitude changes when switching from discontinuous to continuous therapy for diabetic macular oedema
... Objective To investigate if the mean central retinal thickness (CRT) amplitude, measured between visits, is consistently decreased when switching from discontinuous to continuous therapy for diabetic macular ...
6